Holen Sie sich die Stockscreener-App
0.8754
0.75%
-0.0066
Handel nachbörslich:
.88
0.0046
+0.53%
Schlusskurs vom Vortag:
$0.882
Offen:
$0.882
24-Stunden-Volumen:
43,167
Relative Volume:
0.15
Marktkapitalisierung:
$28.47M
Einnahmen:
$950.10K
Nettoeinkommen (Verlust:
$-16.69M
KGV:
-1.0547
EPS:
-0.83
Netto-Cashflow:
$-15.16M
1W Leistung:
-6.12%
1M Leistung:
+2.99%
6M Leistung:
-23.21%
1J Leistung:
-21.84%
1-Tages-Spanne:
$0.87
$0.882
1-Wochen-Bereich:
$0.86
$0.94
52-Wochen-Spanne:
$0.693
$1.80
Femasys Inc Stock (FEMY) Company Profile
Firmenname
Femasys Inc
Sektor
Telefon
770-500-3910
Adresse
3950 JOHNS CREEK COURT, SUWANEE
Vergleichen Sie FEMY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.8754 | 30.33M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Femasys Inc Aktie (FEMY) Neueste Nachrichten
What drives Femasys Inc. stock priceFree Expert Stock Watchlist - jammulinksnews.com
What analysts say about Femasys Inc. stockConsistent high-performance stocks - Autocar Professional
Is Femasys Inc. a good long term investmentSuperior risk-adjusted returns - jammulinksnews.com
Femasys Faces Nasdaq Noncompliance Notice: Stock Price Below $1.00 for 30 Consecutive Business Days - AInvest
Femasys Inc. Stock Analysis and ForecastDynamic capital growth - jammulinksnews.com
Femasys Faces Nasdaq Noncompliance Notice for Stock Price - TipRanks
Femasys receives Nasdaq notice for minimum bid price noncompliance - Investing.com Australia
Femasys receives Nasdaq notice for minimum bid price noncompliance By Investing.com - Investing.com Nigeria
Why Femasys Inc. stock attracts strong analyst attentionTrend Based Entry Alerts - Newser
How Femasys Inc. stock performs during market volatilityShort Term Profit Focus - Newser
What makes Femasys Inc. stock price move sharplyVolume Spike Monitors - Newser
Femasys Enters Purchase Agreement with Alumni Capital - MSN
Femasys Secures $10 Million Financing with Alumni Capital Purchase Agreement - AInvest
Major Breakthrough: Australia and NZ Approve Femasys Revolutionary First-Line Infertility Solutions - Stock Titan
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic - The Manila Times
Femasys Gets Australia, New Zealand Approvals for Two Products - MarketScreener
Femasys stock rises as FemBloc gets CE Mark for permanent birth control - Investing.com
Femasys Receives European Approval for FemBloc Non-Surgical Permanent Birth Control - Femtech Insider
Femasys appoints Kelley Nicholas as chief commercial officer - Investing.com
Femasys appoints Kelley Nicholas as chief commercial officer By Investing.com - Investing.com Canada
Femasys Appoints Kelley Nicholas as Chief Commercial Officer - TipRanks
Femasys (FEMY) Appoints Kelley Nicholas as Chief Commercial Officer | FEMY Stock News - GuruFocus
Femasys appoints Nicholas as CCO - TipRanks
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth - GlobeNewswire
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates - MSN
40,968 Shares in Femasys Inc. (NASDAQ:FEMY) Acquired by Citadel Advisors LLC - Defense World
Femasys (NASDAQ:FEMY) Receives “Buy” Rating from HC Wainwright - Defense World
A Closer Look at Femasys Inc (FEMY) Stock Gains - investchronicle.com
The Analyst Verdict: Femasys In The Eyes Of 6 Experts - Benzinga
Femasys (FEMY): Buy Rating Reiterated by HC Wainwright & Co. | FEMY Stock News - GuruFocus
Femasys: Strategic Partnerships and Revenue Growth Drive Buy Rating with $12 Price Target - TipRanks
Femasys Announces Partnership with Carolinas Fertility - GlobeNewswire
Femasys announces partnership with Carolinas Fertility Institute - TipRanks
Femasys (FEMY) Partners with Carolinas Fertility Institute for FemaSeed Distribution | FEMY Stock News - GuruFocus
Finanzdaten der Femasys Inc-Aktie (FEMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):